PARIS--(BUSINESS WIRE)--Iktos, a company specialized in Artificial Intelligence for new drug design today announced collaboration agreement in AI for new drug design with Chiesi Group, the ...

CAMBRIDGE, England--(BUSINESS WIRE)--DeepMirror, a University of Cambridge spin-out company developing intuitive design software for the discovery of novel therapeutic drugs, today announced the ...

Ateam of UC Santa Barbara engineering and molecular biology graduate students has developed software to accelerate the discovery process for therapies aimed at treating Alzheimer’s and other diseases.

Discover how Optibrium is transforming early-stage drug discovery through AI-powered software, generative chemistry, and 3D modelling. In this interview, Matt Segall, CEO at Optibrium, shares insights ...

Artificial intelligence (AI)-based drug developer Isomorphic Labs said it has raised $600 million in its first external funding round, with the proceeds expected to accelerate its research and ...

Asha Therapeutics has announced its rebranding as First Atom Therapeutics (“First Atom”), marking the company’s evolution as a zero-shot de novo drug design company using AI-enabled molecular design ...

If a picture is worth 1,000 words, a 3D model of a new drug candidate is worth far more. After all, such a model can help the drug candidate’s designers make sense of their voluminous data—which ...

Insilico is part of a wave of companies betting on AI as the "next amazing revolution" in biology Alex Zhavoronkov has been messing around with artificial intelligence for more than a decade. In 2016, ...